ALTHE.PA
Theraclion SA [ALTHE.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALTHE.PA Stock Summary
In the News
ALTHE.PA Financial details
Company Rating
-
Market Cap
16.65M
Income
-8.64M
Revenue
3.05M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
30
Optionable
No
Shortable
Yes
Earnings
21 Mar 2024
P/E
-1.95
Forward P/E
-
PEG
-1.17
P/S
14.1
P/B
20.71
P/C
-
P/FCF
-3.12
Quick Ratio
1.46
Current Ratio
2.17
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
-
EPS this Y
-52.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.18%
Revenue last 5Y
-8.13%
Revenue Q/Q
-14.27%
EPS Q/Q
-68.23%
-
-
-
-
SMA20
-1.43%
SMA50
7.81%
SMA100
35.29%
Inst Own
-
Inst Trans
-
ROA
-42%
ROE
1593%
ROC
-0.73%
Gross Margin
-314%
Oper. Margin
-568%
Profit Margin
-469%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.3-0.848
52W High
-
52W Low
-
RSI
45.32
Rel Volume
1.25
Avg Volume
25.8K
Volume
32.2K
Perf Week
-3.52%
Perf Month
2.81%
Perf Quarter
32.26%
Perf Half Y
9.67%
-
-
-
-
Beta
0.055
-
-
Volatility
0.03%, 0.04%
Prev Close
-0.6%
Price
0.658
Change
-3.24%
Company Profile
- Volume Average 25.8K
- Market Capitalization 16.65M
- Employee 30
- CEO Mr. Martin Deterre
- Headquarters Malakoff,FR
- IPO Date 2014-04-25
-
Website
https://www.theraclion.com 
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
